Prevents nausea and vomiting. ANDA 76183, held by Dr Reddys Labs Ltd. Ondansetron Hydrochloride.
As of Nov 16, 2026, ANDA 76183 (Ondansetron Hydrochloride), held by Dr Reddys Labs Ltd, was first approved by FDA on Dec 26, 2006, with 10 approved supplements and 0 published complete response letters.
Ondansetron tablets are indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2. initial and repeat courses of moderately emetogenic cancer chemotherapy. radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen Ondansetron tablets are also indicated for the prevention of postoperative nausea and/or vomiting.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 26, 2006 | Original application | Approved |
| Ondansetron HydrochlorideEQ 24MG BASE · tablet;oral | Ondansetron Hydrochloride | Discontinued |
| Ondansetron HydrochlorideEQ 8MG BASE · tablet;oral | Ondansetron Hydrochloride | Rx |
| Ondansetron HydrochlorideEQ 4MG BASE · tablet;oral | Ondansetron Hydrochloride | Rx |
| Ondansetron HydrochlorideEQ 16MG BASE · tablet;oral | Ondansetron Hydrochloride | Discontinued |
| Feb 25, 2026 | Supplement 19Labeling · Standard review | Approved | None posted |
| Oct 4, 2023 | Supplement 15Labeling · Standard review | Approved | None posted |
| Oct 4, 2023 | Supplement 14Labeling · Standard review | Approved | None posted |
| Feb 26, 2018 | Supplement 12Labeling · Standard review | Approved | None posted |
| Feb 26, 2018 | Supplement 9Labeling · Standard review | Approved | None posted |
| Feb 26, 2018 | Supplement 7Labeling · Standard review | Approved | None posted |
| Dec 20, 2014 | Supplement 6Labeling · Standard review | Approved | None posted |
| Dec 20, 2014 | Supplement 5Labeling · Standard review | Approved | None posted |
| Feb 13, 2012 | Supplement 3Labeling | Approved | None posted |
| Nov 30, 2010 | Supplement 2Labeling | Approved | None posted |
| Dec 26, 2006 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters